AAPL   323.34 (+0.46%)
MSFT   184.91 (+1.14%)
FB   232.72 (+0.35%)
GOOGL   1,442.31 (+0.52%)
AMZN   2,472.41 (+0.06%)
NVDA   353.01 (+0.22%)
CGC   16.14 (-2.06%)
BABA   214.33 (+3.76%)
MU   46.82 (+1.04%)
GE   7.05 (+4.29%)
TSLA   881.56 (-1.84%)
AMD   53.54 (-0.17%)
T   30.99 (+0.19%)
ACB   14.53 (+3.05%)
F   5.90 (+0.51%)
GILD   73.26 (-2.53%)
DIS   118.75 (-0.02%)
NFLX   427.31 (+0.33%)
BAC   24.84 (+0.93%)
BA   153.31 (+1.27%)
AAPL   323.34 (+0.46%)
MSFT   184.91 (+1.14%)
FB   232.72 (+0.35%)
GOOGL   1,442.31 (+0.52%)
AMZN   2,472.41 (+0.06%)
NVDA   353.01 (+0.22%)
CGC   16.14 (-2.06%)
BABA   214.33 (+3.76%)
MU   46.82 (+1.04%)
GE   7.05 (+4.29%)
TSLA   881.56 (-1.84%)
AMD   53.54 (-0.17%)
T   30.99 (+0.19%)
ACB   14.53 (+3.05%)
F   5.90 (+0.51%)
GILD   73.26 (-2.53%)
DIS   118.75 (-0.02%)
NFLX   427.31 (+0.33%)
BAC   24.84 (+0.93%)
BA   153.31 (+1.27%)
AAPL   323.34 (+0.46%)
MSFT   184.91 (+1.14%)
FB   232.72 (+0.35%)
GOOGL   1,442.31 (+0.52%)
AMZN   2,472.41 (+0.06%)
NVDA   353.01 (+0.22%)
CGC   16.14 (-2.06%)
BABA   214.33 (+3.76%)
MU   46.82 (+1.04%)
GE   7.05 (+4.29%)
TSLA   881.56 (-1.84%)
AMD   53.54 (-0.17%)
T   30.99 (+0.19%)
ACB   14.53 (+3.05%)
F   5.90 (+0.51%)
GILD   73.26 (-2.53%)
DIS   118.75 (-0.02%)
NFLX   427.31 (+0.33%)
BAC   24.84 (+0.93%)
BA   153.31 (+1.27%)
AAPL   323.34 (+0.46%)
MSFT   184.91 (+1.14%)
FB   232.72 (+0.35%)
GOOGL   1,442.31 (+0.52%)
AMZN   2,472.41 (+0.06%)
NVDA   353.01 (+0.22%)
CGC   16.14 (-2.06%)
BABA   214.33 (+3.76%)
MU   46.82 (+1.04%)
GE   7.05 (+4.29%)
TSLA   881.56 (-1.84%)
AMD   53.54 (-0.17%)
T   30.99 (+0.19%)
ACB   14.53 (+3.05%)
F   5.90 (+0.51%)
GILD   73.26 (-2.53%)
DIS   118.75 (-0.02%)
NFLX   427.31 (+0.33%)
BAC   24.84 (+0.93%)
BA   153.31 (+1.27%)
Log in

NASDAQ:CLSDClearside Biomedical News Headlines

$1.85
-0.01 (-0.54 %)
(As of 06/2/2020 04:00 PM ET)
Add
Compare
Today's Range
$1.85
Now: $1.85
$1.95
50-Day Range
$1.74
MA: $1.99
$2.41
52-Week Range
$0.56
Now: $1.85
$4.13
Volume224,900 shs
Average Volume800,391 shs
Market Capitalization$83.01 million
P/E RatioN/A
Dividend YieldN/A
Beta1.07

Headlines

Clearside Biomedical (NASDAQ CLSD) News Headlines

Source:
DateHeadline
 Analysts Expect Clearside Biomedical Inc (NASDAQ:CLSD) Will Post Earnings of -$0.13 Per Share Analysts Expect Clearside Biomedical Inc (NASDAQ:CLSD) Will Post Earnings of -$0.13 Per Share
www.americanbankingnews.com - June 1 at 6:52 PM
Clearside Biomedical Inc (NASDAQ:CLSD) Given Average Rating of "Buy" by BrokeragesClearside Biomedical Inc (NASDAQ:CLSD) Given Average Rating of "Buy" by Brokerages
www.americanbankingnews.com - May 25 at 5:29 AM
BRIEF-Clearside Biomedical Files For Common Stock Offering Of Upto $50 MlnBRIEF-Clearside Biomedical Files For Common Stock Offering Of Upto $50 Mln
www.reuters.com - May 22 at 11:16 PM
Clearside Biomedical Inc (NASDAQ:CLSD) Short Interest Down 10.2% in MayClearside Biomedical Inc (NASDAQ:CLSD) Short Interest Down 10.2% in May
www.americanbankingnews.com - May 20 at 10:40 PM
Critical Survey: Amicus Therapeutics (NASDAQ:FOLD) vs. Clearside Biomedical (NASDAQ:CLSD)Critical Survey: Amicus Therapeutics (NASDAQ:FOLD) vs. Clearside Biomedical (NASDAQ:CLSD)
www.americanbankingnews.com - May 18 at 1:03 PM
Wedbush Brokers Boost Earnings Estimates for Clearside Biomedical Inc (NASDAQ:CLSD)Wedbush Brokers Boost Earnings Estimates for Clearside Biomedical Inc (NASDAQ:CLSD)
www.americanbankingnews.com - May 18 at 1:46 AM
Short Interest in Clearside Biomedical Inc (NASDAQ:CLSD) Declines By 10.2%Short Interest in Clearside Biomedical Inc (NASDAQ:CLSD) Declines By 10.2%
www.americanbankingnews.com - May 14 at 7:39 PM
Clearside Biomedical Inc (NASDAQ:CLSD) CEO George M. Lasezkay Sells 32,150 SharesClearside Biomedical Inc (NASDAQ:CLSD) CEO George M. Lasezkay Sells 32,150 Shares
www.americanbankingnews.com - May 13 at 5:57 PM
Clearside Biomedical (NASDAQ:CLSD) Now Covered by Roth CapitalClearside Biomedical (NASDAQ:CLSD) Now Covered by Roth Capital
www.americanbankingnews.com - May 13 at 4:57 PM
$120,000.00 in Sales Expected for Clearside Biomedical Inc (NASDAQ:CLSD) This Quarter$120,000.00 in Sales Expected for Clearside Biomedical Inc (NASDAQ:CLSD) This Quarter
www.americanbankingnews.com - May 12 at 5:20 AM
Clearside Biomedical Inc (NASDAQ:CLSD) Expected to Post Earnings of -$0.15 Per ShareClearside Biomedical Inc (NASDAQ:CLSD) Expected to Post Earnings of -$0.15 Per Share
www.americanbankingnews.com - May 10 at 4:26 AM
Clearside Biomedical (NASDAQ:CLSD) Issues  Earnings ResultsClearside Biomedical (NASDAQ:CLSD) Issues Earnings Results
www.americanbankingnews.com - May 9 at 12:30 PM
Clearside Biomedical Inc (CLSD) Reports Q1 Loss, Tops Revenue EstimatesClearside Biomedical Inc (CLSD) Reports Q1 Loss, Tops Revenue Estimates
www.nasdaq.com - May 8 at 3:54 PM
Clearside Biomedical EPS beats by $0.05, beats on revenueClearside Biomedical EPS beats by $0.05, beats on revenue
seekingalpha.com - May 8 at 7:51 AM
Clearside Biomedical Announces First Quarter 2020 Financial ResultsClearside Biomedical Announces First Quarter 2020 Financial Results
finance.yahoo.com - May 8 at 7:51 AM
(CLSD) Report Negative Q1 Earnings? What You Should Know(CLSD) Report Negative Q1 Earnings? What You Should Know
www.nasdaq.com - May 6 at 2:22 PM
Will Clearside Biomedical, Inc.
(CLSD) Report Negative Q1 Earnings? What You Should KnowWill Clearside Biomedical, Inc. (CLSD) Report Negative Q1 Earnings? What You Should Know
finance.yahoo.com - May 6 at 2:22 PM
Clearside Bio down 9% on delay in refiling Xipere applicationClearside Bio down 9% on delay in refiling Xipere application
seekingalpha.com - April 28 at 2:04 PM
Clearside Biomedical Revises NDA Resubmission Timeline and XIPERE™ Commercial Partnership with Bausch HealthClearside Biomedical Revises NDA Resubmission Timeline and XIPERE™ Commercial Partnership with Bausch Health
finance.yahoo.com - April 28 at 9:03 AM
Clearside Biomedical Appoints Nancy J. Hutson, Ph.D. to its Board of DirectorsClearside Biomedical Appoints Nancy J. Hutson, Ph.D. to its Board of Directors
finance.yahoo.com - April 22 at 8:50 AM
Clearside Biomedical Establishes Scientific Advisory Board with Distinguished Retinal PhysiciansClearside Biomedical Establishes Scientific Advisory Board with Distinguished Retinal Physicians
finance.yahoo.com - April 9 at 7:33 AM
Clearside Biomedical to Present at the Needham Virtual Healthcare ConferenceClearside Biomedical to Present at the Needham Virtual Healthcare Conference
finance.yahoo.com - April 8 at 11:26 AM
Clearside Biomedical, Inc. Common Stock (CLSD) Latest Real Time TradesClearside Biomedical, Inc. Common Stock (CLSD) Latest Real Time Trades
www.nasdaq.com - March 28 at 8:35 PM
Eye disease pharmaceutical company makes change at top permanentEye disease pharmaceutical company makes change at top permanent
www.bizjournals.com - March 17 at 5:33 PM
Edited Transcript of CLSD earnings conference call or presentation 11-Mar-20 8:30pm GMTEdited Transcript of CLSD earnings conference call or presentation 11-Mar-20 8:30pm GMT
finance.yahoo.com - March 12 at 9:29 AM
Clearside Biomedical, Inc. (CLSD) Reports Q4 Loss, Lags Revenue EstimatesClearside Biomedical, Inc. (CLSD) Reports Q4 Loss, Lags Revenue Estimates
finance.yahoo.com - March 11 at 10:45 PM
Clearside Bio up 16% after hours on Xipere deal in AsiaClearside Bio up 16% after hours on Xipere deal in Asia
seekingalpha.com - March 11 at 5:45 PM
Clearside Biomedical, Inc. to Host Earnings CallClearside Biomedical, Inc. to Host Earnings Call
finance.yahoo.com - March 11 at 5:45 PM
Clearside Biomedical Announces License Agreement with Arctic Vision for XIPERE™ (triamcinolone acetonide suprachoroidal injectable suspension) in Greater China and South KoreaClearside Biomedical Announces License Agreement with Arctic Vision for XIPERE™ (triamcinolone acetonide suprachoroidal injectable suspension) in Greater China and South Korea
finance.yahoo.com - March 11 at 5:45 PM
Clearside Biomedical Appoints Dr. George Lasezkay as President and Chief Executive OfficerClearside Biomedical Appoints Dr. George Lasezkay as President and Chief Executive Officer
finance.yahoo.com - March 11 at 5:45 PM
Clearside Biomedical Announces Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate UpdateClearside Biomedical Announces Fourth Quarter and Full Year 2019 Financial Results and Provides Corporate Update
finance.yahoo.com - March 11 at 5:45 PM
Clearside Biomedical, Inc. (CLSD) Expected to Beat Earnings Estimates: Can the Stock Move Higher?Clearside Biomedical, Inc. (CLSD) Expected to Beat Earnings Estimates: Can the Stock Move Higher?
finance.yahoo.com - March 4 at 6:03 PM
Clearside Biomedical, Inc. Common Stock (CLSD) SEC FilingsClearside Biomedical, Inc. Common Stock (CLSD) SEC Filings
www.nasdaq.com - March 2 at 7:16 AM
Clearside Biomedical to Report Fourth Quarter and Full Year 2019 Financial Results and Provide Corporate Update on Wednesday, March 11, 2020Clearside Biomedical to Report Fourth Quarter and Full Year 2019 Financial Results and Provide Corporate Update on Wednesday, March 11, 2020
finance.yahoo.com - February 27 at 7:10 AM
Clearside Biomedical to Present at Two Upcoming Investor Conferences in March 2020Clearside Biomedical to Present at Two Upcoming Investor Conferences in March 2020
finance.yahoo.com - February 26 at 11:04 AM
Clearside Biomedical Pipeline Highlighted in Oral Presentations at the Annual Angiogenesis and Macula Society MeetingsClearside Biomedical Pipeline Highlighted in Oral Presentations at the Annual Angiogenesis and Macula Society Meetings
finance.yahoo.com - February 25 at 7:26 AM
Clearside Biomedical Announces Presentations to be Given at Angiogenesis and Macula Society ConferencesClearside Biomedical Announces Presentations to be Given at Angiogenesis and Macula Society Conferences
finance.yahoo.com - February 5 at 7:36 AM
Will Clearside Biomedical Continue to Surge Higher?Will Clearside Biomedical Continue to Surge Higher?
finance.yahoo.com - January 20 at 9:08 AM
Clearside Biomedical (CLSD) Presents At 38th Annual J.P. Morgan Healthcare Conference - SlideshowClearside Biomedical (CLSD) Presents At 38th Annual J.P. Morgan Healthcare Conference - Slideshow
seekingalpha.com - January 17 at 12:27 PM
Clearside holders file to offer 3.18M sharesClearside holders file to offer 3.18M shares
seekingalpha.com - January 10 at 8:24 PM
Calculating The Intrinsic Value Of Clearside Biomedical, Inc. (NASDAQ:CLSD)Calculating The Intrinsic Value Of Clearside Biomedical, Inc. (NASDAQ:CLSD)
finance.yahoo.com - December 31 at 8:31 AM
Is Estre Ambiental, Inc. (ESTR) Going To Burn These Hedge Funds ?Is Estre Ambiental, Inc. (ESTR) Going To Burn These Hedge Funds ?
finance.yahoo.com - December 20 at 10:07 PM
Is the Options Market Predicting a Spike in Clearside Biomedical (CLSD) Stock?Is the Options Market Predicting a Spike in Clearside Biomedical (CLSD) Stock?
finance.yahoo.com - December 18 at 12:16 PM
ROKU, APA, ORMP and CLSD among notable midday moversROKU, APA, ORMP and CLSD among notable midday movers
seekingalpha.com - December 2 at 2:44 PM
These 3 Biotech Stocks Could More Than Double in 2020, Says WedbushThese 3 Biotech Stocks Could More Than Double in 2020, Says Wedbush
finance.yahoo.com - November 29 at 11:12 AM
Edited Transcript of CLSD earnings conference call or presentation 6-Nov-19 9:30pm GMTEdited Transcript of CLSD earnings conference call or presentation 6-Nov-19 9:30pm GMT
finance.yahoo.com - November 22 at 1:51 PM
Clearside Biomedical to Present at the Stifel 2019 Healthcare ConferenceClearside Biomedical to Present at the Stifel 2019 Healthcare Conference
finance.yahoo.com - November 13 at 5:36 PM
Clearside Biomedical, Inc. (CLSD) CEO George Lasezkay on Q3 2019 Results - Earnings Call TranscriptClearside Biomedical, Inc. (CLSD) CEO George Lasezkay on Q3 2019 Results - Earnings Call Transcript
seekingalpha.com - November 10 at 2:55 PM
Clearside Biomedical, Inc. (CLSD) Reports Q3 Loss, Tops Revenue EstimatesClearside Biomedical, Inc. (CLSD) Reports Q3 Loss, Tops Revenue Estimates
finance.yahoo.com - November 6 at 10:57 PM
Clearside Biomedical EPS misses by $0.01, beats on revenueClearside Biomedical EPS misses by $0.01, beats on revenue
seekingalpha.com - November 6 at 5:56 PM
This page was last updated on 6/2/2020 by MarketBeat.com Staff

Enter your email address below to receive a concise daily summary of analysts' upgrades, downgrades and new coverage with MarketBeat.com's FREE daily email newsletter.